We're Hopeful That Design Therapeutics (NASDAQ:DSGN) Will Use Its Cash Wisely [Yahoo! Finance]
Design Therapeutics, Inc. (DSGN)
Company Research
Source: Yahoo! Finance
By way of example, Design Therapeutics NASDAQ:DSGN ) has seen its share price rise 160% over the last year, delighting many shareholders. Nonetheless, only a fool would ignore the risk that a loss making company burns through its cash too quickly. So notwithstanding the buoyant share price, we think it's well worth asking whether Design Therapeutics' cash burn is too risky. In this article, we define cash burn as its annual (negative) free cash flow, which is the amount of money a company spends each year to fund its growth. We'll start by comparing its cash burn with its cash reserves in order to calculate its cash runway. See our latest analysis for Design Therapeutics A company's cash runway is calculated by dividing its cash hoard by its cash burn. In June 2024, Design Therapeutics had US$261m in cash, and was debt-free. In the last year, its cash burn was US$51m. So it had a cash runway of about 5.1 years from June 2024. While this is only one measure of its cash burn situa
Show less
Read more
Impact Snapshot
Event Time:
DSGN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DSGN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DSGN alerts
High impacting Design Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
DSGN
News
- Design Therapeutics to Participate in Multiple Upcoming Investor ConferencesGlobeNewswire
- Design Therapeutics GAAP EPS of -$0.23 beats by $0.02 [Seeking Alpha]Seeking Alpha
- Design Therapeutics Announces Third Quarter 2024 Financial Results and Reviews Near-term Milestones for GeneTACTM PortfolioGlobeNewswire
DSGN
Earnings
- 11/7/24 - Beat
DSGN
Sec Filings
- 12/19/24 - Form 4
- 11/7/24 - Form 10-Q
- 11/7/24 - Form 8-K
- DSGN's page on the SEC website